Drug Patents owned by Eyepoint Pharms
1. List of Dexycu Kit drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7560120 | EYEPOINT PHARMS | Vehicles for delivery of biologically active substances |
Sep, 2022
(8 months ago) | |
| US6960346 | EYEPOINT PHARMS | Vehicles for delivery of biologically active substances |
Jul, 2023
(a month from now) | |
| US10799642 | EYEPOINT PHARMS | Dose guides for injection syringe |
May, 2032
(8 years from now) | |
| US10028965 | EYEPOINT PHARMS | Use of sustained release dexamethasone in post-cataract surgery inflammation |
May, 2034
(10 years from now) | |
| US10159683 | EYEPOINT PHARMS | Use of sustained release dexamethasone in post-cataract surgery inflammation |
May, 2034
(10 years from now) | |
| US10022502 | EYEPOINT PHARMS | Dose guides for injection syringe |
Jun, 2034
(11 years from now) | |
| US11097061 | EYEPOINT PHARMS | Systems, kits and methods for loading and delivering a small volume dose from a syringe |
Jun, 2039
(16 years from now) | |
Drugs and Companies using DEXAMETHASONE ingredient
Market Authorisation Date: 09 February, 2018
Treatment: Treatment of postoperative inflammation; A method of loading medication into a syringe and delivering the medication to a treatment site
Dosage: SUSPENSION;INTRAOCULAR
DEXYCU KIT family patents
20
United States
4
China
4
Australia
4
European Union
3
Canada
3
Japan
3
Korea, Republic of
2
Spain
1
Denmark
1
RS
1
Poland
1
Brazil
1
New Zealand
1
Croatia
1
Israel
1
Portugal
1
Mexico
1
Lithuania
1
Slovenia
1
Hungary
2. List of Yutiq drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8871241 | EYEPOINT PHARMS | Injectable sustained release delivery devices |
Aug, 2027
(4 years from now) | |
| US7998108 | EYEPOINT PHARMS | Injector apparatus and method of use |
Jan, 2028
(4 years from now) | |
Drugs and Companies using FLUOCINOLONE ACETONIDE ingredient
Market Authorisation Date: 12 October, 2018
Treatment: A method of injecting an implant
Dosage: IMPLANT;INTRAVITREAL
YUTIQ family patents
52
United States
13
Japan
12
China
12
European Union
11
Australia
9
Canada
9
Taiwan
7
Spain
7
Denmark
7
Argentina
7
Slovenia
6
Austria
6
Korea, Republic of
6
Mexico
5
Germany
5
Brazil
5
New Zealand
4
Cyprus
4
Portugal
3
Poland
2
Hong Kong
2
Israel
2
South Africa
1
Malaysia
1
India
1
EA
1
Norway
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic